Olga Efimova

1.0k total citations
45 papers, 801 citations indexed

About

Olga Efimova is a scholar working on Oncology, Epidemiology and Biophysics. According to data from OpenAlex, Olga Efimova has authored 45 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Epidemiology and 9 papers in Biophysics. Recurrent topics in Olga Efimova's work include Pancreatic and Hepatic Oncology Research (6 papers), Electron Spin Resonance Studies (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Olga Efimova is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Electron Spin Resonance Studies (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Olga Efimova collaborates with scholars based in United States, Russia and United Kingdom. Olga Efimova's co-authors include P. J. Hore, Todd W. Kelley, Philippe Szankasi, Christiane R. Timmel, Hannah J. Hogben, Sergey Petryakov, Jay L. Zweíer, Alexandre Samouilov, Charles A. Hales and Valery V. Khramtsov and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Olga Efimova

42 papers receiving 787 citations

Peers

Olga Efimova
Mikhail Y. Berezin United States
Suman Ranjit United States
Chris Dunsby United Kingdom
Joe T. Sharick United States
Arjen N. Bader Netherlands
Rafał Panek United Kingdom
M.L. Johnson United States
Damian Bird Australia
Mikhail Y. Berezin United States
Olga Efimova
Citations per year, relative to Olga Efimova Olga Efimova (= 1×) peers Mikhail Y. Berezin

Countries citing papers authored by Olga Efimova

Since Specialization
Citations

This map shows the geographic impact of Olga Efimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Efimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Efimova more than expected).

Fields of papers citing papers by Olga Efimova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Efimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Efimova. The network helps show where Olga Efimova may publish in the future.

Co-authorship network of co-authors of Olga Efimova

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Efimova. A scholar is included among the top collaborators of Olga Efimova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Efimova. Olga Efimova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Григорьева, И. Н., et al.. (2023). Metabolic Risk Factors and Their Impact on Quality of Life in Patients with Pancreatic Cancer, Acute or Exacerbated Chronic Pancreatitis. SHILAP Revista de lepidopterología. 33(3). 49–60.
2.
Григорьева, И. Н., et al.. (2021). Frequency of hyperglycemia and polymorphism of TNF and TP53 genes in patients with acute pancreatitis, chronic pancreatitis, pancreatic cancer. SHILAP Revista de lepidopterología. 24(6). 511–520. 1 indexed citations
3.
Hung, Anna, Kyung Min Lee, Patrick R. Alba, et al.. (2021). EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer. Cancer Treatment and Research Communications. 27. 100327–100327. 2 indexed citations
4.
Григорьева, И. Н. & Olga Efimova. (2021). Risk factors for pancreatitis and pancreatic cancer. Terapevticheskii arkhiv. 93(8). 875–882. 1 indexed citations
5.
Hung, Anna, Kyung Min Lee, Julie A. Lynch, et al.. (2021). Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer. BMC Cancer. 21(1). 824–824. 4 indexed citations
6.
Lynch, Kristine E., et al.. (2018). Comparison of automated and retrospectively calculated estimated glomerular filtration rate in electronic health record data. BMC Nephrology. 19(1). 380–380. 1 indexed citations
7.
Efimova, Olga, et al.. (2017). CANCER OF THE PANCREAS. SOME OF THE MOLECULAR AND GENETIC MECHANISMS OF CARCINOGENESIS AS A TARGET FOR THERAPY. Experimental and Clinical Gastroenterology. 138(2). 103–109.
8.
Hull, Leland E., Julie A. Lynch, Brygida Berse, et al.. (2017). Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care. Clinical Breast Cancer. 18(2). 135–143. 3 indexed citations
9.
Efimova, Olga, Brygida Berse, Scott L. DuVall, et al.. (2017). Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Medical Informatics and Decision Making. 17(1). 71–71. 5 indexed citations
10.
Kovacsovics‐Bankowski, Magdalena, Todd W. Kelley, Olga Efimova, et al.. (2015). Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2 V617F allelic burden. Experimental Hematology and Oncology. 5(1). 28–28. 17 indexed citations
11.
Salama, Mohamed E., Shouying Du, Olga Efimova, et al.. (2014). Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities. Leukemia & lymphoma. 56(2). 426–433. 3 indexed citations
12.
Samouilov, Alexandre, Olga Efimova, Andrey A. Bobko, et al.. (2013). In Vivo Proton–Electron Double-Resonance Imaging of Extracellular Tumor pH Using an Advanced Nitroxide Probe. Analytical Chemistry. 86(2). 1045–1052. 46 indexed citations
13.
Gahring, Lorise C., Elena Y. Enioutina, Gerald J. Spangrude, et al.. (2013). Nicotinic Receptor Alpha7 Expression Identifies a Novel Hematopoietic Progenitor Lineage. PLoS ONE. 8(3). e57481–e57481. 24 indexed citations
14.
Efimova, Olga, V. Murugesan, Mohamed A. El‐Mahdy, et al.. (2011). Organ specific mapping of in vivo redox state in control and cigarette smoke-exposed mice using EPR/NMR co-imaging. Journal of Magnetic Resonance. 216. 21–27. 29 indexed citations
15.
Efimova, Olga, Sergey Petryakov, David H. Johnson, et al.. (2011). Variable radio frequency proton–electron double-resonance imaging: Application to pH mapping of aqueous samples. Journal of Magnetic Resonance. 209(2). 227–232. 16 indexed citations
16.
Efimova, Olga, Philippe Szankasi, & Todd W. Kelley. (2011). Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+ Effector T Cells. PLoS ONE. 6(1). e16013–e16013. 90 indexed citations
17.
Bobko, Andrey A., Timothy D. Eubank, Jeffrey L. Voorhees, et al.. (2011). In vivo monitoring of pH, redox status, and glutathione using L‐band EPR for assessment of therapeutic effectiveness in solid tumors. Magnetic Resonance in Medicine. 67(6). 1827–1836. 76 indexed citations
18.
Szankasi, Philippe, Albert K. Ho, David W. Bahler, Olga Efimova, & Todd W. Kelley. (2010). Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features. Leukemia Research. 35(2). 200–207. 12 indexed citations
19.
Efimova, Olga & P. J. Hore. (2007). Role of Exchange and Dipolar Interactions in the Radical Pair Model of the Avian Magnetic Compass. Biophysical Journal. 94(5). 1565–1574. 143 indexed citations
20.
Efimova, Olga, et al.. (2006). Injection of prostaglandin F2α into the bronchial artery in sheep increases the pulmonary vascular permeability to protein. Pulmonary Pharmacology & Therapeutics. 20(2). 167–171. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026